487 related articles for article (PubMed ID: 7678867)
1. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
[TBL] [Abstract][Full Text] [Related]
2. [Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16, and their synergistic modulation of multidrug resistance].
Naito M; Tsuruo T
Gan To Kagaku Ryoho; 1994 Feb; 21(3):395-402. PubMed ID: 7906507
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of reversing effect of cyclosporin A on vincristine resistance by anti-P-glycoprotein monoclonal antibody MRK-16.
Naito M; Tsuge H; Kuroko C; Tomida A; Tsuruo T
Jpn J Cancer Res; 1993 May; 84(5):489-92. PubMed ID: 8100562
[TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance by an immunosuppressive agent FK-506.
Naito M; Oh-hara T; Yamazaki A; Danki T; Tsuruo T
Cancer Chemother Pharmacol; 1992; 29(3):195-200. PubMed ID: 1370765
[TBL] [Abstract][Full Text] [Related]
5. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
[TBL] [Abstract][Full Text] [Related]
6. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
Watanabe T; Naito M; Kokubu N; Tsuruo T
J Natl Cancer Inst; 1997 Apr; 89(7):512-8. PubMed ID: 9086008
[TBL] [Abstract][Full Text] [Related]
7. Functionally active homodimer of P-glycoprotein in multidrug-resistant tumor cells.
Naito M; Tsuruo T
Biochem Biophys Res Commun; 1992 May; 185(1):284-90. PubMed ID: 1350903
[TBL] [Abstract][Full Text] [Related]
8. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.
Sela S; Husain SR; Pearson JW; Longo DL; Rahman A
J Natl Cancer Inst; 1995 Jan; 87(2):123-8. PubMed ID: 7707383
[TBL] [Abstract][Full Text] [Related]
10. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.
Pearson JW; Fogler WE; Volker K; Usui N; Goldenberg SK; Gruys E; Riggs CW; Komschlies K; Wiltrout RH; Tsuruo T
J Natl Cancer Inst; 1991 Oct; 83(19):1386-91. PubMed ID: 1681110
[TBL] [Abstract][Full Text] [Related]
11. Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein.
Matsuo H; Wakasugi M; Takanaga H; Ohtani H; Naito M; Tsuruo T; Sawada Y
J Control Release; 2001 Nov; 77(1-2):77-86. PubMed ID: 11689261
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.
Watanabe T; Tsuge H; Oh-Hara T; Naito M; Tsuruo T
Acta Oncol; 1995; 34(2):235-41. PubMed ID: 7718262
[TBL] [Abstract][Full Text] [Related]
13. Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein.
Broxterman HJ; Kuiper CM; Schuurhuis GJ; Tsuruo T; Pinedo HM; Lankelma J
Biochem Pharmacol; 1988 Jun; 37(12):2389-93. PubMed ID: 2898943
[TBL] [Abstract][Full Text] [Related]
14. Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
Shrivastava P; Hanibuchi M; Yano S; Parajuli P; Tsuruo T; Sone S
Cancer Chemother Pharmacol; 1998; 42(6):483-90. PubMed ID: 9788575
[TBL] [Abstract][Full Text] [Related]
15. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.
Naito M; Tsuruo T
Cancer Res; 1989 Mar; 49(6):1452-5. PubMed ID: 2924298
[TBL] [Abstract][Full Text] [Related]
16. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
Sato W; Fukazawa N; Suzuki T; Yusa K; Tsuruo T
Cancer Res; 1991 May; 51(9):2420-4. PubMed ID: 1673087
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.
Ishida Y; Ohtsu T; Hamada H; Sugimoto Y; Tobinai K; Minato K; Tsuruo T; Shimoyama M
Jpn J Cancer Res; 1989 Oct; 80(10):1006-13. PubMed ID: 2575608
[TBL] [Abstract][Full Text] [Related]
18. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.
Dalton WS; Grogan TM; Meltzer PS; Scheper RJ; Durie BG; Taylor CW; Miller TP; Salmon SE
J Clin Oncol; 1989 Apr; 7(4):415-24. PubMed ID: 2564428
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cole SP; Sparks KE; Fraser K; Loe DW; Grant CE; Wilson GM; Deeley RG
Cancer Res; 1994 Nov; 54(22):5902-10. PubMed ID: 7954421
[TBL] [Abstract][Full Text] [Related]
20. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]